Home/Filings/4/0001078782-20-000262
4//SEC Filing

Micallef Jacob Vincent 4

Accession 0001078782-20-000262

CIK 0000093314other

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 4:57 PM ET

Size

5.5 KB

Accession

0001078782-20-000262

Insider Transaction Report

Form 4
Period: 2020-04-13
Micallef Jacob Vincent
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-04-13+70,00070,000 total
    Exercise: $3.60From: 2021-04-13Exp: 2026-04-13Common Stock (70,000 underlying)
Footnotes (1)
  • [F1]A total of 70,000 Options were granted on April 13, 2020 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.

Issuer

VOLITIONRX LTD

CIK 0000093314

Entity typeother

Related Parties

1
  • filerCIK 0001651671

Filing Metadata

Form type
4
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 4:57 PM ET
Size
5.5 KB